» Articles » PMID: 35273997

Composite Paraganglioma of the Celiac Trunk: A Case Report and a Comprehensive Review of the Literature

Overview
Journal Front Surg
Specialty General Surgery
Date 2022 Mar 11
PMID 35273997
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Composite paragangliomas consist of two components, paraganglioma and ganglioneuroma, representing a rare subgroup of paragangliomas. The purpose of the study is to describe a case of composite paraganglioma of the celiac trunk and a brief review of the existing literature.

Case Presentation: A 64-year-old female patient with a history of epigastric abdominal pain and a 51 mm-diameter tumor found in a Computerized Tomography of the abdomen was admitted to our surgical department for further evaluation and treatment. After a brief preoperative surgical assessment, the patient underwent a mini-laparotomy for the excision of this tumor. After having the results of the pathology report, a comprehensive review of the international literature was carried out by applying the appropriate search terms.

Results: As it was found intraoperatively, the tumor was located at the cephalad aspect of the common hepatic artery, over the portal vein and the inferior vena cava. A negative-margin resection was achieved and the tumor was sent for pathology analysis. The final pathology report revealed a composite paraganglioma, with α paraganglioma and a ganglioneuroma component. Seventeen cases of extra-adrenal composite paraganglioma have been reported in the international literature so far. This case was the first one found in the area of the celiac trunk.

Conclusions: Composite paragangliomas comprise rare and potentially malignant tumors with variable prognosis. Establishing their diagnosis promptly is of vital significance. Due to the first-described location of the composite paraganglioma in our case, the differential diagnosis of tumors in this area should also include composite paragangliomas.

Citing Articles

Construction and validation of a prognostic model for predicting overall survival of primary adrenal malignant tumor patients: A population-based study with 1,080 patients.

Xie W, Zhang Y, Cao R Front Surg. 2022; 9:1025213.

PMID: 36353609 PMC: 9637840. DOI: 10.3389/fsurg.2022.1025213.


Case Report: Composite pheochromocytoma with ganglioneuroma component: A report of three cases.

Araujo P, Carvallo M, Vidal A, Nascimento J, Wo J, Naliato E Front Endocrinol (Lausanne). 2022; 13:903085.

PMID: 36187102 PMC: 9515550. DOI: 10.3389/fendo.2022.903085.


A rare case report of multifocal para-aortic and para-vesical paragangliomas.

Xiong S, Di X, Zhang M, Wu K, Li X Front Endocrinol (Lausanne). 2022; 13:946496.

PMID: 36004346 PMC: 9393499. DOI: 10.3389/fendo.2022.946496.

References
1.
Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y . Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol. 2005; 16(1):23-32. DOI: 10.1385/ep:16:1:023. View

2.
Dhir M, Li W, Hogg M, Bartlett D, Carty S, McCoy K . Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma. Ann Surg Oncol. 2017; 24(12):3624-3630. DOI: 10.1245/s10434-017-6074-1. View

3.
Wohllk N, Schweizer H, Erlic Z, Schmid K, Walz M, Raue F . Multiple endocrine neoplasia type 2. Best Pract Res Clin Endocrinol Metab. 2010; 24(3):371-87. DOI: 10.1016/j.beem.2010.02.001. View

4.
Hamidi O . Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management. Curr Opin Endocrinol Diabetes Obes. 2019; 26(3):146-154. DOI: 10.1097/MED.0000000000000476. View

5.
Leavitt J, Harold D, Robinson R . Adrenal ganglioneuroma: a familial case. Urology. 2000; 56(3):508. DOI: 10.1016/s0090-4295(00)00695-6. View